title: Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study.
abstract: The associations between fasting plasma insulin concentration and risk factors for cardiovascular disease were examined in 979 18-year-old men participating in the Verona Young Men Atherosclerosis Risk Factors Study, a cross-sectional population-based study. Body mass index (BMI), waist-to-hip ratio (WHR), plasma triglycerides and uric acid concentrations, and blood pressure values significantly increased, and the high-density lipoprotein (HDL)-total cholesterol ratio decreased, across quartiles of fasting insulin. Total and low-density lipoprotein cholesterol, concentrations did not change significantly with the increase in fasting insulin levels. After adjustment for BMI, WHR, smoking, alcohol intake and physical activity, only plasma triglycerides significantly increased across insulin quartiles (F = 7.1; P < 0.001). However, systolic blood pressure and uric acid were close to statistical significance (P = 0.06-0.07). Multiple linear regression analysis confirmed that plasma insulin was independently correlated with plasma triglycerides and, to a lesser extent, with blood pressure and uric acid concentration. This analysis pointed out that BMI was a stronger independent predictor of all cardiovascular disease risk factors than fasting insulin. When subjects were categorized according to the number of metabolic and haemodynamic disorders occurring within the same individual, subjects with multiple disorders (i.e, three or four) had higher plasma insulin levels than those with none or few disorders, even after adjusting for BMI, WHR and behavioural variables (F = 4.0; P < 0.01). These results indicate that hyperinsulinaemia is already associated with a cluster of cardiovascular disease risk factors in young adulthood, the strongest independent association being with plasma triglycerides.
authors.affiliation: Division of Endocrinology and Metabolic Diseases, University of Verona Medical School, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Bonora
authors.forename: G
authors.initials: G
authors.lastname: Targher
authors.forename: M B
authors.initials: MB
authors.lastname: Zenere
authors.forename: F
authors.initials: F
authors.lastname: Saggiani
authors.forename: V
authors.initials: V
authors.lastname: Cacciatori
authors.forename: F
authors.initials: F
authors.lastname: Tosi
authors.forename: D
authors.initials: D
authors.lastname: Travia
authors.forename: M G
authors.initials: MG
authors.lastname: Zenti
authors.forename: P
authors.initials: P
authors.lastname: Branzi
authors.forename: L
authors.initials: L
authors.lastname: Santi
authors.forename: M
authors.initials: M
authors.lastname: Muggeo
mesh_terms: D000293:Adolescent; D001161:Arteriosclerosis / Q000097:blood* / Q000209:etiology*; D001794:Blood Pressure; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000097:blood* / Q000209:etiology*; D003430:Cross-Sectional Studies; D005215:Fasting / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000097:blood*; D007558:Italy; D008055:Lipids / Q000097:blood; D008297:Male; D012307:Risk Factors; D014527:Uric Acid / Q000097:blood
chemical_list: D007328:Insulin; D008055:Lipids; D014527:Uric Acid